Introduction {#s1}
============

Hepatitis B virus (HBV) infection is still a major public health problem worldwide.[@R1] Around 90% of infants infected perinatally become chronic carriers, unless vaccinated at birth. Approximately 25% of persons who became chronically infected during childhood and 15% of persons chronically infected after childhood die of cirrhosis or liver cancer.[@R2]

In 1989, the Brazilian government implemented HBV immunization for infants in the western area of the Amazonas State because of the high prevalence, and gradually expanded the program to the other northern states. In 1993, states in south and southeast regions extended immunization up to the age of 4 years. In 1998, the HBV vaccine was incorporated into the immunization schedule for infants as a national policy.[@R3] Subsequently, children and adolescents (2001), young adults up to 29 years (2011) of age, and adults up to 49 years (2013) of age were included. Vaccination of risk groups started in 1992, and new groups were successively added to the original list.

A population-based survey conducted in 27 Brazilian cities among 17,749 children aged 18--30 months in 2007 estimated that 86.7% completed the three-dose series by 12 months of age.[@R4]

Most of the Brazilian territory has been classified as having intermediate and low endemicity for HBV infection, the exception being the high-HBV endemicity area located in the western Amazon region and restricted areas of some states in the south and southeast regions.[@R5]

A national population-based hepatitis survey was thus conducted aiming at estimating the prevalence of HBV infection and its predictive factors after about 10--20 years of the beginning of vaccination. Here we report the results for all the state capitals from the north, south, and southeast regions. Results showing low prevalence in the northeast and central-west regions and in the Federal District of Brasília have already been published.[@R6]

Materials and Methods {#s2}
=====================

Study populations and study samples. {#s2a}
------------------------------------

The Brazilian National Hepatitis A, B, and C Survey is a cross-sectional household study in a representative sample of the population resident in all the state capitals and in the federal district.

We report on the hepatitis B survey conducted in the southeast (four capital cities), south (three capital cities), and north (seven capital cities) regions, during March 2007--January 2008 ([Figure 1](#F1){ref-type="fig"} Figure 1.Distribution of population aged 13--69 years in the state capitals of the North, South and Southeast Regions of Brazil and of the census tracts, households and individuals sampled.). The target population (10--69 years of age) comprised 14.9 million inhabitants in the southeast region, 2.6 million in the south, and 2.9 million in the north region.

More detailed information on sampling and data collection has already been reported.[@R7] In brief, the study population was stratified into two age strata (10--19 and 20--69 years) and by state capital in each region; the samples for each age group were allocated among the state capitals using a constant sampling fraction. A random sample was obtained using a multistage cluster sampling strategy based on census tract, which is the smallest geographic unit with sociodemographic data available (approximately 300 households corresponding to 1,000 inhabitants). To improve sampling efficiency, the census tracts were, when necessary, either broken up or grouped together according to preestablished criteria to make the primary sampling unit (PSU). The PSUs were then ordered according to the number of years of schooling of the head of household, and a systematic sample was taken from this ordered list of PSUs, with probability proportional to size, so that all socioeconomic groups would be represented. In the second stage, blocks were systematically selected with probability proportional to size within each PSU and, finally, a systematic sampling of households was drawn in each block. All residents in the age group considered were recruited in the selected households. Number of years of schooling of the head of household was selected to order the census tracts because it is strongly correlated with income.

A total of 10,184 individuals were enrolled in the study: 3,689 persons in 1,842 households living in 154 census tract in the southeast region; 4,189 persons in 2,047 households located in 91 census tracts in the south region; and 2,306 persons in 1,084 households living in 213 census tracts in the north region.

### Data collection. {#s2a1}

Data on socioeconomic status and potential risk factors were collected by trained interviewers using a structured questionnaire during household visits. Self-reported HBV vaccine status was assessed and confirmed by the vaccination card, when available.

### Laboratory tests and definitions. {#s2a2}

Blood samples were collected after the interview and tested for antibodies against hepatitis B core antigen (HBc) using an enzyme-linked immunosorbent assay (AxsymTM; Abbott Laboratories, Abbott Park, IL) in central public health laboratories. Positive samples were tested for antibodies against hepatitis B surface antigen (HBs); samples negative for antibodies against hepatitis B surface antigen (anti-HBs) were tested for hepatitis B surface antigen (HBsAg), using the same technique (AxsymTM). Borderline results were retested and indeterminate results were excluded from the analysis.

Chronic HBV infection was determined as the presence of HBsAg and anti-HBc. The presence of HBV infection, past or present, was determined by detection of anti-HBc, in accordance with the National Health and Nutritional Examination Survey.[@R8]

### Statistical analysis. {#s2a3}

Prevalence and 95% confidence intervals (95% CI) were corrected by the design effect. Risk factors comprised questions on drug use and sexual practice, and therefore the analysis included only persons aged 13--69 years. Association between HBV infection and individual variables, adjusted by age, was assessed by odds ratio (OR) with a 95% CI. Variables associated in bivariate analyses with *P* \< 0.20 were successively included in a multivariate logistic regression model. ORs were corrected using the random design effect caused by the study design and weighting caused by the difference in sampling fractions between age groups.

For participants who presented a vaccination card, the predictive positive and negative values of the self-reported HBV vaccination status were estimated.

Stata, version 9.2 (College Station, TX), was used for statistical analysis.

### Sample size. {#s2a4}

Details on sample size and sampling procedures have already been published.[@R7]

### Ethical issues. {#s2a5}

Interviews and blood sample collection were performed after a written informed consent was signed. For minors, the legal guardian consent was obtained. The project was approved by the National Research Ethics Committee of the Brazilian National Health Council and by the local research ethics committees.

Each positive result was delivered by the medical coordinator, and all negative results were sent by mail to participants. Individuals who were positive for HBsAg were referred to hepatology or infectology outpatient clinics in public referral hospitals for clinical evaluation. Persons negative for HBV were referred to public health services for vaccination.

Results {#s3}
=======

Prevalence. {#s3a}
-----------

The prevalence of anti-HBc stratified according to region and age group is shown in [Table 1](#T1){ref-type="table"}. The prevalence in the age group 10--19 years was higher in the south whereas that in the age group 20--69 years was higher in the north.

A total of 15, 14, and 21 carriers were identified in the north, southeast and south, respectively.

Vaccination status was reported by approximately 78% of the population in all regions. Of the 3,338 participants who presented a vaccination card, the predictive positive and negative values of the self-reported HBV vaccination status were 90.38% (95% CI: 87.03--93.10%) and 75.47% (95% CI: 61.72--86.24%) for the north, 95.97% (95% CI: 94.50--97.13%) and 96.21% (95% CI: 91.38--98.76%) for the south, and 95.67% (95% CI: 94.11--96.92%) and 89.45% (95% CI: 84.59--93.19%) for the southeast region. Approximately 45.6% reported HBV vaccination. Residents of the north region reported higher frequencies of HBV vaccination (56%) compared with those in the south (41%) and southeast (40%) regions. Vaccination status for persons aged ≥ 20 years was significantly higher in the north compared with the south and southeast regions ([Table 1](#T1){ref-type="table"}).

### Bivariate analysis. {#s3a1}

[Tables 2](#T2){ref-type="table"}--[5](#T5){ref-type="table"} show the association of individual risk factors with HBV infection, adjusted by age. For sexual behavioral factors, in the bivariate analysis, the reference category was that with lower potential of transmission (among those who had initiated sexual life), whereas in the multivariate, the reference was those who had not started sexual life. In the north region, having a bisexual partner, another sexual partner besides current partner, and use of smoked drugs (marijuana, crack cocaine) were statistically associated with HBV infection. In the southeast, male gender, presence of tattoo, use of smoked or inhaled drugs (shoe glue, toluene), and heavy alcohol consumption were all associated with HBV infection. In the south, the characteristics associated with HBV infection were blood transfusion in the past 12 months, sharing toothbrush, initiated sexual life, no use of condom, previous sexually transmitted disease (STD), another sexual partner besides current partner, and use of inhaled, sniffed (cocaine), or injected drugs.

### Multivariable analysis. {#s3a2}

The multivariate model showed that age was an independent risk factor in all regions ([Table 6](#T6){ref-type="table"}). Socioeconomic condition was associated with HBV infection in north and south regions. Variables related to the blood route transmission were associated with HBV infection only in the south whereas those related to sexual behavior were associated in the north and south regions. Drug use was associated in all regions, but the type of drug differed. The south was the region with a wider spectrum of risk factors.

Discussion {#s4}
==========

Knowledge of region- and age-specific prevalence of hepatitis B infection is important for evaluating vaccination programs and national disease prevention and control efforts. Our findings classify these regions as having low HBV endemicity, rather than the intermediate and high endemicity defined by previous studies in the last century and past decade. Nevertheless, the overall estimation of individuals chronically infected with HBV was 18,612, 43,367, and 12,624 in the north, southeast, and south, respectively.

The introduction of vaccination in these regions happened in different years and in different age groups. In the data collection period, vaccinated cohorts might have reached the age of 20 years. Note that in the north, area that was considered as having high prevalence, the vaccination status for participants over 20 years of age was significantly higher compared with the south and southeast regions.

Countries with high prevalence of HVB infection that began universal immunization have shown decreased prevalence, as occurred in Taiwan,[@R9],[@R10] China,[@R11],[@R12] and Saudi Arabia.[@R13] A reduction was also observed in low-endemicity countries, such as the United States[@R14] and Canada.[@R15]

In Brazil, a population-based study in the western Amazon State, in a region called Labrea (where the association of hepatitis B and D virus infection was first identified), revealed a significant reduction in the HBsAg rate in the community, 11 years after the introduction of the HBV vaccination program, categorizing the area as intermediate endemicity (formerly classified as high).[@R16]

Our data revealed a prevalence of HBsAg similar to the data for all capitals of the northeast, central-west regions, and in the federal capital.[@R6]

Although population-based data for HBV infection before and after vaccination are not available for large areas, the low-endemicity level found strongly suggest an impact of the vaccination policy. The Brazilian National Immunization Program attained high vaccination coverage and sustainability as vaccines were freely supplied by the National Self-Sufficiency Program in Immunobiologicals.[@R17]

Recent publication with the objective of estimating age-, sex-, and region-specific prevalence of chronic HBV infection in the world and calculate the absolute number of persons chronically infected, using an empirical Baysian hierarchical model, showed that from 1990 to 2005 the prevalence of chronic HBV infection decreased in most regions. Brazil was categorized as a region of low endemicity.[@R18]

The results of this survey indicate different patterns of HBV transmission in the areas studied. The factors independently associated with HBV infection in the north region were mainly related to the sexual route and to the use of drugs; in the southeast to the use of drugs; while in the south to the sexual route, use of drugs and also to the blood route. An inverse relationship with socioeconomic conditions (schooling) was found in the north and south regions. Use of drugs that were not related to the mechanism of transmission of HBV was also associated with seropositivity.

Age was an independent predictor for HBV infection, as reported in the literature,[@R19] indicating length of time for viral exposures and initiation of sexual activity. The increasing vaccine coverage of younger age groups may also have contributed to the difference in prevalence between the two age groups considered (10--19 and 20--69 years). Our study found higher risk of HBV infection in men only in the southeast region, like in the United States[@R20] and in Brazilian studies with individuals recruited from restricted areas, volunteers, or outpatient clinics.[@R21]--[@R23]

The sexual behavior associated with exposure to HBV was not the same in the different regions. In the north, there was a greater chance of HBV infection for those whose partner had sex with individuals of the same sex, similar to what was found in the northeast.[@R6] Male--male sexual activity[@R24],[@R25] and having a homosexual partner[@R26] have been reported as risk factors for HBV infection in other studies. Individuals whose partners have sex with individuals of the same sex share, to some extent, the same risk factors of their partners. The association between the number of sexual partners and the positivity to serologic markers of hepatitis B (and other STDs) is often referred in Brazilian studies carried out either in blood centers[@R27],[@R28] or in general population[@R29] or, still, in special groups.[@R30],[@R31]

These sexual behaviors, found in the north and south regions, were probably related to unsafe sexual practices. The history of STD also expresses these practices. The Brazilian Ministry of Health has conducted several campaigns to promote responsible sexual behavior and has made condoms largely available.[@R32] Further efforts could be done to deliver interventions and to conduct in-depth studies to target groups until the age group with high anti-HBV vaccination coverage gets older.

In the southeast, HBV infection was associated with the use of injected drugs; this association is well documented in the literature and in Brazilian studies.[@R25],[@R33] In the three regions, the use of non-injecting drugs was also associated with the presence of HBV infection. It is likely that in these settings non-injecting drug users are more prone to other risk behavior, which should be investigated to allow the choice of targeted control measures. The same rationale could be used to explain the association with heavy alcohol consumption in the southeast.

Sharing toothbrush was associated with HBV infection, inexplicably, in the region with higher Human Development Index. The association with history of blood transfusion and gastrointestinal endoscopy in the south should be interpreted with caution. As in Brazil the blood supply is adequately screened for hepatitis B since 1975, it is possible that either the transfusion occurred before this year or that the exposure to HBV occurred before the transfusion. Endoscopy-related transmission of HBV is rare.[@R34] Quasi-experimental designs (before and after studies) could be performed to elucidate if blood transfusion and endoscopy still play any role in HBV transmission in southern Brazil.

Schooling was associated with exposure to HBV in the south region. Risk behaviors related to the socioeconomic context could be identified to guide specific interventions. Sewage disposal was associated with HBV infection in the north and south regions, but the association was in opposite directions suggesting that the same situation (household with septic tank) may express different socioeconomic conditions in these two regions. The results for hepatitis C for the whole country showed that no sewage disposal, a marker of extreme poverty, was associated with anti-hepatitis C virus prevalence.[@R35]

The study has some limitations and strengths. The main strength is that it is a representative sample of the population aged 10--69 years of the ensemble of state capitals in the north, south, and southeast regions. However, the results may not be directly extrapolated to the residents of smaller cities or rural areas. Another limitation is temporal ambiguity, which is inherent to cross-sectional studies. Information bias, especially in relation to questions related to the use of drugs and sexual behavior, may have occurred but, as individuals did not know the results of their blood testing when interviewed, it was nonrandom, which may have decreased the magnitude of some of the associations found.

The findings presented herein highlight the diversity of the potential transmission routes for hepatitis B transmission in Brazil. In one hand, it reinforces the importance of national control strategies of large impact already in course such as the immunization of infants, adolescents, and adults up to 49 years of age and blood supply screening. On the other hand, it shows that there is still room for further control measures targeted to different groups within each region.
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###### 

Prevalence of hepatitis B antibodies, percentage of individuals vaccinated for hepatitis B, and estimated population ever infected in a representative sample of individuals living in the state capitals of Brazil, 2005--2009

  Setting age (years) group   Participants   Prevalence[\*](#TFN2){ref-type="table-fn"} % (95% CI)   Vaccination status (%)   State capitals population   Estimated persons ever infected *n* (95% CI)
  --------------------------- -------------- ------------------------------------------------------- ------------------------ --------------------------- ----------------------------------------------
  North                                                                                                                                                   
   10--19                     1,157          1.1 (0.9--1.4)                                          68.9                     860,922                     9,471 (7,749--12,053)
   20--69                     1,149          11.6 (10.7--12.4)                                       49.8                     2,093,269                   242,820 (223,980--259,356)
  Southeast                                                                                                                                               
   10--19                     1,794          0.61 (0.27--0.95)                                       67.4                     3,295,110                   20,100 (8,897--31,304)
   20--69                     1,867          7.90 (6.60--9.19)                                       23.2                     11,661,984                  921,297 (769,691--1,071,737)
  South                                                                                                                                                   
   10--19                     1,801          1.58 (0.83--2.32)                                       76.2                     586,270                     9,264 (4,867--13,602)
   20--69                     2,373          11.3 (9.94--12.7)                                       24.0                     2,043,761                   230,944 (203,150--259,558)

CI = confidence interval.

Prevalence adjusted for random effect.

###### 

Relative odds of hepatitis B infection for individual factors among persons of 13--69 years of age in three regions in Brazil, 2005--2009

  Individual factors    North   Southeast           South                                                                   
  --------------------- ------- ------------------- ------- ------- ------------------- ------- ------- ------------------- -------
  Sex                                                                                                                       
   Female               1,094   1.0                 --      1,739   1.0                 --      1,977   1.0                 --
   Male                 875     1.39 (1.01--1.91)   0.041   1,368   1.60 (1.13--2.26)   0.007   1.650   1.19 (0.94--1.50)   0.141
  Literacy                                                                                                                  
   Yes                  1,909   1.0                 --      3,009   1.0                 --      3,536   1.0                 --
   No                   56      2.93 (1.47--5.84)   0.002   98      0.67 (0.31--1.42)   0.303   91      0.95 (0.53--1.69)   0.870
  Schooling                                                                                                                 
   Illiterate           112     1.0                         190     1.0                         180     1.0                 
   Basic level          797     0.61 (0.37--0.99)   0.047   1,389   1.06 (0.62--1.79)   0.823   1,404   0.81 (0.55--1.19)   0.293
   Secondary level      814     0.59 (0.32--1.05)   0.075   1,172   0.84 (0.45--1.54)   0.578   1,428   0.58 (0.37--0.90)   0.016
   University           217     0.34 (0.16--0.71)   0.004   334     0.47 (0.21--1.07)   0.074   580     0.41 (0.24--0.70)   0.001
  Paid work past week                                                                                                       
   Yes                  813     1.0                 --      1,420   1.0                 --      1,839   1.0                 --
   No                   1,156   0.54 (0.40--0.73)   0.000   1,687   0.86 (0.60--1.23)   0.420   1,787   1.00 (0.77--1.31)   0.966
  Hospitalization                                                                                                           
   Never                1,203   1.0                 --      2,216   1.0                 --      2,458   1.0                 --
   Past 12 months       182     0.77 (0,42--1,40)   0.388   168     1.02 (0.47--2.20)   0.948   189     1.27 (0.80--2.02)   0.307
   Ever                 559     1.04 (0.69--1.56)   0.847   718     1.07 (0.70--1.64)   0.726   979     1.26 (0.98--1.62)   0.071
  Blood transfusion                                                                                                         
   Never                1,815   1                   --      2,894   1.0                 --      3,289   1.0                 --
   Past 12 months       44      1.45 (0.50--4.20)   0.494   40      1.41 (0.51--3.92)   0.505   45      2.57 (1.36--4.86)   0.004
   Ever                 62      1.65 (0.82--3.32)   0.157   136     1.45 (0.72--2.94)   0.294   282     0.78 (0.49--1.23)   0.296
  Surgery                                                                                                                   
   Never                1,177   1                   --      1,725   1.0                 --      1,754   1.0                 --
   Past 12 months       180     0.98 (0.58--1.65)   0.946   270     1.39 (0.82--2.34)   0.211   358     1.23 (0.79--1.90)   0.347
   Ever                 591     0.71 (0.49--1.02)   0.066   1,109   1.24 (0.80--1.92)   0.322   1,504   0.97 (0.72--1.30)   0.852

CI = confidence interval; OR = odds ratio.

Weighted ORs adjusted for random effect and age.

###### 

Relative odds of hepatitis B infection for drug use--related factors among persons of 13--69 years of age in three regions in Brazil, 2005--2009

  Drug use-related factors        North   Southeast           South                                                                   
  ------------------------------- ------- ------------------- ------- ------- ------------------- ------- ------- ------------------- -------
  Ever used smoked drugs                                                                                                              
   No                             1,651   1.0                 --      2,814   1.0                 --      3,038   1.0                 --
   Yes                            191     1.73 (1.19--2.55)   0.005   290     1.72 (1.08--2.73)   0.022   570     1.31 (0.87--1.97)   0.187
  Ever used inhaled drugs                                                                                                             
   No                             1,902   1.0                 --      3,068   1.0                 --      3,512   1.0                 --
   Yes                            35      1.67 (0.75--3.67)   0.204   31      4.98 (1.60--15.5)   0.006   90      2.39 (1.13--5.05)   0.022
  Ever used sniffed drugs                                                                                                             
   No                             1,877   1.0                 --      2,969   1.0                 --      3,392   1.0                 --
   Yes                            71      2.75 (1.28--5.87)   0.009   134     1.53 (0.74--3.16)   0.241   216     1.95 (1.14--3.31)   0.014
  Ever used injected drugs                                                                                                            
   No                             1,922   1.0                 --      3,084   1.0                 --      3,577   1.0                 --
   Yes                            9       --                  --      13      1.41 (0.24--8.09)   0.695   21      3.55 (1.31--9.61)   0.013
  Previous use of glass syringe                                                                                                       
   No                             1,604   1.0                 --      2,627   1.0                 --      2,753   1.0                 --
   Yes                            316     0.73 (0.47--1.15)   0.178   444     0.78 (0.54--1.12)   0.186   824     1.19 (0.89--1.58)   0.223
  Alcohol consumption                                                                                                                 
   None                           1,368   1.0                 --      1,968   1.0                 --      2,077   1.0                 --
   Light                          472     0.87 (0.61--1.25)   0.455   978     1.10 (0.74--1.63)   0.627   1,364   1.02 (0.77--1.34)   0.878
   Heavy                          141     1.66 (0.92--2.98)   0.093   159     2.32 (1.31--4.09)   0.004   176     1.37 (0.75--2.51)   0.296

CI = confidence interval; OR = odds ratio.

Weighted ORs adjusted for random effect and age.

###### 

Factors associated with hepatitis B infection in three regions of Brazil, 2005

  Characteristics                   North               Southeast   South                                           
  --------------------------------- ------------------- ----------- ------------------- ------- ------------------- -------
  Sex                                                                                                               
   Female                           --                  --          1.0                 --      --                  --
   Male                             --                  --          1.49 (1.02--2.19)   0.041   --                  --
  Age (in years)                    1.05 (1.03--1.06)   0.000       1.06 (1.05--1.08)   0.000   1.04 (1.03--1.05)   0.000
  Read and write                                                                                                    
   Yes                              1.0                 --          --                  --      --                  --
   No                               3.14 (1.53--6.46)   0.002       --                  --      --                  --
  Schooling                                                                                                         
   Illiterate                       --                  --          --                  --      1.0                 --
   Basic level                      --                  --          --                  --      0.78 (0.53--1.15)   0.214
   Secondary level and university   --                  --          --                  --      0.51 (0.32--0.81)   0.004
  Paid work past week                                                                                               
   Yes                              1.0                 --          --                  --      --                  --
   No                               0.56 (0.40--0.76)   0.000       --                  --      --                  --
  Sewage disposal                                                                                                   
   Pubic system                     1.0                 --          --                  --      1.0                 --
   Septic tanks                     0.61 (0.40--0.93)   0.021       --                  --      1.71 (1.28--2.29)   0.000
   Other destination                0.83 (0.40--1.72)   0.617       --                  --      --                  --
  Blood transfusion                                                                                                 
   Never                            --                  --          --                  --      1.0                 --
   Past 12 months                   --                  --          --                  --      2.28 (1.11--4.67)   0.024
   Ever                             --                  --          --                  --      0.68 (0.41--1.15)   0.152
  Endoscopy                                                                                                         
   Never                            --                  --          --                  --      1.0                 --
   Past 12 months                   --                  --          --                  --      1.27 (0.80--2.05)   0.311
   Ever                             --                  --          --                  --      1.33 (0.99--1.80)   0.059
  Share toothbrush                                                                                                  
   No                               --                  --          --                  --      1.0                 --
   Yes                              --                  --          --                  --      1.81 (1.05--3.12)   0.032
  Condom use                                                                                                        
   Not started sexual life          --                  --          --                  --      1.0                 --
   Yes, regularly                   --                  --          --                  --      2.41 (0.96--6.06)   0.060
   Yes, sometimes                   --                  --          --                  --      3.68 (1.65--8.22)   0.001
   Never                            --                  --          --                  --      3.90 (1.54--9.88)   0.004
  Bisexual partner                                                                                                  
   Not started sexual life          1.0                             --                  --      --                  --
   No                               2.37 (0.87--6.42)   0.089       --                  --      --                  --
   Yes                              1.68 (1.17--2.41)   0.005       --                  --      --                  --
  Ever used smoked drugs                                                                                            
   No                               1.0                 --          --                  --      --                  --
   Yes                              1.58 (1.05--2.36)   0.026       --                  --      --                  --
  Ever used inhaled drugs                                                                                           
   No                               --                  --          1.0                 --      --                  --
   Yes                              --                  --          3.85 (1.19--12.4)   0.024   --                  --
  Ever sniffed drugs                                                                                                
   No                               --                  --          --                  --      1.0                 --
   Yes                              --                  --          --                  --      1.73 (1.01--2.97)   0.048
  Ever injecting drugs                                                                                              
   No                               --                  --          --                  --      1.0                 --
   Yes                              --                  --          --                  --      2.49 (0.82--7.54)   0.106
  Classification elitism                                                                                            
   Abstemious                       --                  --          --                  --      --                  --
   Light weight drinker             --                  --          0.95 (0.63--1.44)   0.815   --                  --
   Heavy drinker                    --                  --          1.96 (1.06--3.59)   0.030   --                  --

CI = confidence interval; OR = odds ratio.

Adjusted ORs corrected for random effect and weighted for age group.
